Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
Neuropeptides ; 65: 90-99, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28716393

ABSTRACT

After spinal cord injury (SCI) there are many recoveries inhibiting factors such as chondroitin sulfate proteoglycan (CSPG) and inflammation. The present study investigated the combinational effect of low level laser therapy (LLLT) as anti-inflammatory agent and Chondroitinase ABC (ChABC) enzyme as CSPG digesting factor on spinal cord after injury. This study performed on 44 male Wistar rats, spinal cord injury induced by a clip compression injury. Animals received two-weeks treatment of 660nm low level laser (LLL) and intraspinal injection of 1µg ChABC. Functional recovery, cavity size, myelination, axonal projections around the cavity, fibroblast invasion and expression of glycogen synthase kinase-3ß (GSk 3ß), CSPG and aquaporin 4 (AQP4) expression were evaluated. In statistical evaluation p<0.05 considered significant. Result showed the combination of LLLT and ChABC have more effect on reduction of cavity size, improvement of myelination and number of axons around the cavity and decreasing the expression of GSK3ß, CSPG and AQP4 expression compared to LLLT and ChABC alone. In the laser and laser+enzyme groups AQP4 expression decreased significantly after SCI. Functional recovery, improved in LLLT and ChABC treated animals, but higher recovery belonged to the combination therapy group. The current study showed combination therapy by LLLT and ChABC is more efficient than a single therapy with each of them.


Subject(s)
Chondroitin ABC Lyase/therapeutic use , Low-Level Light Therapy , Nerve Regeneration , Spinal Cord Injuries/therapy , Animals , Anti-Inflammatory Agents/therapeutic use , Aquaporin 4/metabolism , Chondroitin Sulfate Proteoglycans/metabolism , Disease Models, Animal , Fibroblasts/metabolism , Glycogen Synthase Kinase 3 beta/metabolism , Inflammation/complications , Inflammation/therapy , Male , Myelin Sheath/pathology , Rats, Wistar , Recovery of Function , Spinal Cord Injuries/complications , Spinal Cord Injuries/metabolism , Spinal Cord Injuries/pathology
SELECTION OF CITATIONS
SEARCH DETAIL